timothy grass pollen allergen extract (Grastek) Report issue

Allergen Approved FDA
AACT

Active Ingredient History

NOW
  • Now
Timothy is an abundant perennial grass native to most of Europe except for the Mediterranean region. It is also known as timothy-grass, meadow cat's-tail or common cat's tail. It is a member of the genus Phleum, consisting of about 15 species of annual and perennial grasses.   Wikipedia

Chemistry

More Chemistry

Pharmacology

Alternative names

depigold grasses | grass allergen | grass allergen extract | grass mata | grass pollen | grass pollen allergen | grass pollen allergen extract | grass pollen allergens | grass-spire | grastek | pollens - grasses, timothy phleum pratense | purethal grasses | sublivac grasses | timothy grass allergen | timothy grass pollen allergen extract | toleromune grass

Organizations (48)

Research & Development (48)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (15)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (15)


 

Allergy and Immunology (Phase 3)

Amblyopia (Phase 3)

Anisometropia (Phase 3)

Asthma (Phase 3)

Conjunctivitis (Phase 4)

Conjunctivitis, Allergic (Phase 3)

Healthy Volunteers (Phase 2)

Hypersensitivity (Phase 4)

Hypersensitivity, Immediate (Phase 3)

Immunotherapy (Phase 4)

Rhinitis (Phase 3)

Rhinitis, Allergic (Phase 4)

Rhinitis, Allergic, Perennial (Phase 3)

Rhinitis, Allergic, Seasonal (Phase 4)

Strabismus (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 63
  • # of Trial Organizations: 48

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue